These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6425707)

  • 1. Relationships between intracranial pressure and diurnal prolactin secretion in primary empty sella.
    Maira G; Anile C; Cioni B; Menini E; Mancini A; De Marinis L; Barbarino A
    Neuroendocrinology; 1984 Feb; 38(2):102-7. PubMed ID: 6425707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid pressure and prolactin in empty sella syndrome.
    Maira G; Anile C; De Marinis L; Mancini A; Barbarino A
    Can J Neurol Sci; 1990 Feb; 17(1):92-4. PubMed ID: 2107018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure.
    Barbarino A; De Marinis L; Mancini A; D'Amico C; Sambo P; Passeri M; Anile C; Maira G
    Horm Res; 1987; 27(3):141-51. PubMed ID: 3121488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms.
    Kapcala LP; Molitch ME; Arno J; King LW; Reichlin S; Wolpert SM
    J Endocrinol Invest; 1984 Oct; 7(5):455-60. PubMed ID: 6439770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P; Combes ME; Perret G; Attali JR
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
    Celani MF; Giambuzzi G; Simoni M; Montanini V
    J Endocrinol Invest; 1987 Aug; 10(4):421-5. PubMed ID: 3119699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronobiological study of pituitary adenomas and of the empty sella syndrome.
    Ferrari E; Bossolo PA; Baldi F; Daguati M; Fioravanti M; Facara S
    Chronobiologia; 1982; 9(2):241-8. PubMed ID: 7117046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome.
    Malarkey WB; Goodenow TJ; Lanese RR
    Am J Med; 1980 Dec; 69(6):886-90. PubMed ID: 7192490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pituitary: cerebrospinal fluid barrier in the primary empty sella syndrome.
    Spissu A; Angioni G; Fratta W
    Acta Neurol (Napoli); 1982 Aug; 4(4):306-13. PubMed ID: 6295076
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid-dopaminergic interactions in primary empty sella.
    Mancini A; Conte G; Fiumara C; Fabrizi ML; Iacona T; Zuppi P; Colosimo C; De Marinis L
    Exp Clin Endocrinol; 1993; 101(5):277-82. PubMed ID: 8299703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin in cluster headache: diurnal secretion, response to thyrotropin-releasing hormone, and relation to sex steroids and gonadotropins.
    Waldenlind E; Gustafsson SA
    Cephalalgia; 1987 Mar; 7(1):43-54. PubMed ID: 3107837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
    Timmerman W; Poelman RT; Westerink BH; Schuiling GA
    Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease.
    Krieger DT; Howanitz PJ; Frantz AG
    J Clin Endocrinol Metab; 1976 Feb; 42(2):260-72. PubMed ID: 816805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian pattern of prolactin secretion in children with growth hormone deficiency and congenital organic lesions in the hypothalamic-pituitary region.
    Stawerska R; Lewiński A; Smyczyńska J; Hilczer M; Kowalska E; Kaniewska D; Karasek M
    Neuro Endocrinol Lett; 2007 Dec; 28(6):765-74. PubMed ID: 18063946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary function in patients with evidence of spontaneous disappearance of a pituitary adenoma.
    Lindholm J; Bjerre P; Riishede J; Gyldensted C; Hagen C
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):599-603. PubMed ID: 6883732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary empty sella syndrome in a series of 142 patients.
    Maira G; Anile C; Mangiola A
    J Neurosurg; 2005 Nov; 103(5):831-6. PubMed ID: 16304986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial pressure in patients with the empty sella syndrome without benign intracranial hypertension.
    Kaye AH; Tress BM; Brownbill D; King J
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):209-16. PubMed ID: 7086441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dynamic pressure study of spontaneous CSF rhinorrhea in the empty sella syndrome. Case report.
    Davis S; Kaye AH
    J Neurosurg; 1980 Jan; 52(1):103-5. PubMed ID: 7350267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors.
    Schroeder LL; Johnson JC; Malarkey WB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1255-60. PubMed ID: 1002815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-cerebrospinal fluid barrier for prolactin in empty sella syndrome.
    Coculescu M; Temeli E; Oprescu M; Simionescu N
    Endocrinologie; 1981; 19(3):199-206. PubMed ID: 7291947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.